Sent to Worthington:
Sent to me:
Top 6 Marijuana Bills to Follow
Lawmakers have been busy introducing a variety of marijuana bills since the election. While there is no guarantee that any of these bills will actually become laws, a perusal of the bills introduced offers useful insight into how the decisions made regarding cannabis might affect our lives more immediately than the slow churn of Washington, D.C.
In the current political climate, it is more important than ever to spend some time getting familiar with these bills. Please click on the links below to get more information about each proposed bill. We strongly encourage you to get in touch with your elected representatives to express your views and opinions.
Here are the six (6) cannabis-related bills that are worth following closely:
Read the rest of the Story here at medicaljane.com
2017 Legislative Session begins January 9th are you ready?
I wonder if in this session anything will be done to help the medical cannabis patient. The Law from 1998 is no longer what it was. So much has happened to patients who require more than the amount allowed recreational users. Read the home page here to find out what happened and the laws that were passed.
In years past patients were called fakers, the illicit market and the people who would return to the black market. But in reality, patients with serious illnesses have relied on medical cannabis to save their lives when western medicine could not help, when their doctors sent them home to make arrangements, or to those small children who suffer with diseases only helped by cannabis. Those are the ones affected by what has happened in Washington state. This state forced patients to find the only thing that worked for them, anyway they could. For patients it isn’t about getting high or recreating, it is about having a better quality of life when their doctors have given up on them, it is about being able to walk to do housework or get through a day of work without pain, it is about a child not having seizures for as many days possible.
Lets hope that this year Washington state finds compassion in it’s heart because so many people have suffered and are suffering because of the greed that this state allowed to happen by listening to paid, corporate, big pharma lobbyists. Patients do not have time to wait.Share this:
The essential elements of providing your own medical medical marijuana, including:
* Food Feeding cycles. Macro and micro-nutrients
* Lighting PAR , cycles, using power efficiently
* Growing mediums. Soil, non-soil, hydroponics
* Air: controlling temperature, humidity, CO2, ventilation
*Efficiency: selecting the correct equipment, what gauges and
measuring tools to own, continuous quality improvement
* Controlling pests safely.
* Harvesting; The basics of flushing, drying and curing.
* Cost: $20 Class time approximately 90 to 105 minutes.
* Max class size 12 people.
The event page can be found here:
Contact: 206 618 0576. email@example.com
What will be done with he money?
$15 of every $20.00 received will go to John Worthington’s case. The explanation of the case is here:
by Denise Harrington, July 5, 2016
(Patient, and One of the People for Medical Cannabis in Washington State)
- Patients are no longer able to find the medicines that work for them. Every patient is different and what works for one will not necessarily work for another.This is because different strains contain different amounts of different types of cannabinoids. There are currently 111 known cannabinoids in the cannabis plant. Sometimes it takes months, or even years for a cannabis patient to find what works best for their particular illness or condition.
- Not all forms of medical cannabis that was available in the self-regulated medical market will even be available under the new system. Many cannabis patients use edibles or specific types of cannabis oil for treatment Just like different strains of cannabis have different effects so do different forms of cannabis. Some patients use Rick Simpson oil; others use full extract cannabis oil. Many patients make their own oil from the plants they grow themselves. This allows them to tailor their oils to what
works best for them. Under the new policies patients in most cases will not be able to grow enough of their own cannabis for this process. The prices to purchase raw cannabis in the recreational market is too high for the majority of patients to even be able to purchase enough cannabis to make oil.
- Under the new medical cannabis laws patients can no longer grow together to save on costs unless they start a small communal garden, register it with the state, and it must be located at one patients’ residence. Patients must also contribute sweat labor to the growing of the plants. The requirements mean many patients cannot take advantage of belonging to such a garden. Those with physical ailments that limit their movement or those with intense pain, those who are wheelchair bound, those who are shut ins they cannot contribute physical labor so communal growing is out for these patients.
- Dosages patients need to effectively treat themselves are not available in the recreational cannabis market. The highest dosage available is 50Mg. Just like different strains and forms work differently for different patients, different patients need different dosages. For some patients 50Mg may work fine. However, for others they may need dosages of up to 500Mg. This means some patients would need to consume 10 maximum doses of cannabis edibles to get the same affect they would get with 1 dose before. The same goes with the strength of concentrates and even cannabis flower. The maximum under the new policies is woefully inadequate for some patient’s needs. Now you may ask where the DOH came up with the dosages. Well they originally wanted 10Mg max dosage, however patients repeatedly told them this was way too low so Ms. Weeks decided 50Mg was fine. She did not ask patients or even medical professionals she just plucked a number out of the air. Patients deserve better. Ms. Weeks is not qualified to decide patients dosages. That is a job for a doctor, nurse practitioner or other medical professional.
- The no share policy. Under the recreational market users are not allowed to share. Each person who wants to smoke/ingest cannabis must buy their own. This rule has been extended to the medical cannabis policy as well. This means even patients who reside together or even married couples have to purchase their medical needs separately from each other with each patient paying 37% tax to the state. The only reason for this rule is greed. Many cannabis patients are senior citizens or disabled people on a limited income. They should not have to pay double taxes for medicine being used in the same household.
- Children are now allowed in recreational cannabis stores! Yes, you read that right. Under the new medical cannabis policies patients of any age can be in the store to get their medication. Those under the age of 18 must have their designated provider (usually a parent or guardian) for them to enter the store. This means babies, toddlers, kids of all ages can now enter. Kids do not belong in cannabis stores ever! In the self-regulated medical cannabis market children under the age of 18 have not been allowed. They do not need to be there among the pipes, bongs and other paraphernalia associated with cannabis. Most child patients use oil. They do not even associate their medicine with recreational cannabis and they should not.
- Patient’s rights to privacy are obliterated under the new DOH policies. First there is the unneeded “voluntary” registry. Ms. Weeks said in DOH emails that were accessed by FOIA requests that if they needed to justify the registry they could just say “other states have them” Those other states however did not have legal recreational cannabis when the registries were created. The registries were needed to determine who could legally use cannabis in those states. Under the new DOH policies a patient’s medical condition must be shown on the form. This is no one’s business but the patient and their physician! Ms. Weeks said if asked they would just say that Americans for Safe Access recommends it. She also said the info was just too good to pass up. ASA does not represent all or even the majority of patients and should not be looked at in making policy decisions. Make no mistake the DOH does not consider registration to be voluntary at all. In many instances patients have been told by the DOH and by the recreational stores that patients must register. Patients who choose not to register get fewer plants allowed, less medicine they are able to buy and according to DOH no equal protection under the law. The DOH should not be able to require someone to volunteer for anything in order to have equal legal rights! Other state data bases have had data breaches making patients have concerns of identity theft. There are also concerns about the sheer number of agencies that can access patient’s information.
- Ms. Weeks has stated that she knows change is hard but patients will just have to adjust to the new market. Many patients however do not have the time to adjust as she calls it. Patients with Cancer, HIV, Fibromyalgia, Crohn’s disease, MS, Dravets, Zellweger syndrome, and many other diseases and disorders are often running out of time already. Others have made amazing progress using cannabis medicines. Some of those patients will die before they can “adjust” others such as children with various seizure disorders may lose all progress they have made before they “adjust” This is simply not acceptable.
- Simply not enough medical cannabis available. The truth is there is no incentive for cannabis growers to grow medical cannabis. There is also little to no reason for stores to stock it. Much of the cannabis that medical patients use is not attractive to the recreational market. It may have too low a THC content, or may not have effects that recreational users want or some they do not want. There are also many places in Washington that have laws against cannabis shops of any type. This leaves many patients without any access to the cannabis they use medically.
- The pesticide/chemical problem. There are many pesticides and other chemicals allowed in the manufacture and processing of recreational cannabis. There have also been instances of unlawful pesticides being used on cannabis destined for the recreational market. While those pesticides and other chemicals may not harm a healthy adult user, for those with compromised immune systems they can cause severe problems. In the self-regulated medical market many patients used grower’s markets where they could ask questions of the growers including what chemicals/pesticides were used. Most medical cannabis growers use non chemical pest control. Medical cannabis is also in a lot of cases grown in an extremely sterile environment. This is needed to make sure that nothing potentially harmful enters the grow space. In the new “medical” cannabis market patients do not know what chemicals or pesticides were used or under what conditions their medical cannabis was grown. For many patients this is crucial information.
Washington cannabis patients need safe, consistent and affordable access to the medicines they use. They need the person overseeing cannabis policy for the DOH to be knowledgeable about medical cannabis and one who has patients best interest in mind. Ms. Weeks is a legal person. Her function is to keep the DOH out of legal trouble and to defend them if they are sued. She has the DOH’s best interest in mind not the health and best interest of cannabis patients.
The recent Bill to enable the domestic cultivation and production of medicinal cannabis will overcome state laws that have restricted access to the drug in the past, writes Dr Teresa Nicoletti.
In a ground-breaking session in the Federal Parliament, the Minister for Health, Sussan Ley, introduced the much-awaited Narcotic Drugs Amendment Bill 2016 (Bill), which proposes to introduce a legislative framework enabling the cultivation of cannabis in Australia and facilitating access to medicinal cannabis for therapeutic purposes.
The introduction of the Bill follows the announcement by the Commonwealth government last October, which foreshadowed amendments to the Narcotic Drugs Act 1967 (Act) to enable the cultivation of cannabis for medicinal and scientific purposes, and facilitate the manufacture of medicinal cannabis products for use in accordance with the provisions of the Therapeutic Goods Act 1989.
In a heartfelt address to Parliament, Minister Ley said: “Deputy Speaker, many people have worked incredibly hard for this day. For the day that the National Parliament provides the missing piece in the patient’s journey when it comes to accessing safe, reliable, legal medicinal cannabis. It is a very proud day for many members and senators as I said who have worked hard. For those in the community who have advocated strongly, who have pushed, who have prodded, who have expressed their passion loudly and determinedly … and others who treat patients who are convinced of the efficacy and the relief that is provided by these products, they should be recognised here today.”
The Explanatory Memorandum to the Bill states that it has been introduced in response to theRegulator of Medicinal Cannabis Bill 2014, which was introduced into Parliament in November 2014 and referred to the Senate Legal and Constitutional Affairs Legislation Committee in February 2015, which tabled its report in August 2015. The amendments that the Bill will introduce will purportedly address the issues raised by the Senate Committee in its report.
The Bill, if passed, will ensure that Australia will comply with its obligations as a signatory to the United Nations Single Convention on Narcotic Drugs 1961, in relation to any cultivation of cannabis and manufacture of medicinal cannabis products in Australia.
In this regard, the Bill proposes to establish a licensing scheme for the cultivation of cannabis and manufacture of medicinal cannabis products. The key features of the scheme include:
- a mechanism to apply for and obtain a licence authorising the cultivation of cannabis for the purpose of manufacturing medicinal cannabis products;
- a mechanism to apply for and obtain a licence authorising research into cannabis plants to be used for medicinal purposes;
- a strict ‘fit and proper person’ test, which will be applied to any applicant for a licence and any relevant business associates of the applicant;
- in relation to a licence for the cultivation of cannabis for the purpose of manufacturing medicinal cannabis products, a requirement to demonstrate that supply arrangements exist with a licensed manufacturer;
- a permit system that will control the amount of cannabis that can be produced and which, other than in the case of research, will only be granted if a contract exists between the licence holder and a licensed manufacturer;
- strict licensing conditions to ensure that appropriate security and controls are in place; and
- substantial penalties for breaches of conditions and for undertaking unauthorised activities.
Based on the key features of the scheme and as is evident from the Explanatory Memorandum, the Bill contemplates a grower obtaining a licence as long as they are able to demonstrate the ability to supply a licensed manufacturer; and a manufacturer obtaining a licence as long as they are able to demonstrate a legitimate supply chain. The Explanatory Memorandum notes that in this way, the legislation will ensure that there is an appropriate supply chain, without the possibility of oversupply or excess production, which creates a risk of diversion.
The amendments to the Act are intended to complement existing pathways under the Therapeutic Goods Act 1989 (TG Act), which provide for lawful access to cannabis for medicinal use. Under the TG Act, medicinal cannabis products that have not been approved by the TGA may be used in individual patients where a medical practitioner deems that it is in the best interests of their patients. However, importation of medicinal cannabis by this mechanism is subject to licence and permit approvals required under the Customs (Prohibited Imports) Regulations 1956, and could also be subject to State and Territory requirements, which in some cases may be a barrier to access.
This issue will be to a large extent overcome by the new legislation, which will establish an Australian cultivation and production scheme that enables the domestic production of cannabis raw materials and the manufacture of high-quality, safe medicinal cannabis products that can be prescribed by medical practitioners under the existing provisions of the TG Act.
The introduction of the Bill is a major breakthrough for stakeholders who have been advocating strongly for the past two years to legalise the cultivation and production of cannabis for medicinal purposes. It is likely to garner enormous support from medical practitioners, patients, industry stakeholders, the wider community and both sides of government, which should facilitate its fast passage through both Houses of Parliament.
Lawyersweekly.com/au – 16 February 2016…Dr Teresa Nicoletti.
Read Meagan Holts Story about her Daughter Maddie! Shame on you Washington State!